| 1. |
Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders[J]. Neurology, 2015, 85(2): 177-189. DOI: 10.1212/WNL.0000000000001729.
|
| 2. |
Patrick P, Monika B, Romana H, et al. Myelin oligodendrocyte glycoprotein: deciphering a target in inflammatory demyelinating diseases[J]. Front Immunol, 2017, 8: 529. DOI: 10.3389/fimmu.2017.00529.
|
| 3. |
Thulasirajah S, Pohl D, Davilaacosta J, et al. Myelin oligodendrocyte glycoprotein- associated pediatric central nervous system demyelination: clinical course, neuroimaging findings, and response to therapy[J]. Neuropediatrics, 2016, 47(4): 245-252. DOI: 10.1055/s-0036-1583184.
|
| 4. |
Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis[J]. Lancet, 2004, 364(9451): 2106-2112. DOI: 10.1016/S0140-6736(04)17551-X.
|
| 5. |
Mariotto S, Ferrari S, Monaco S, et al. Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study[J]. J Neurol, 2017, 264(12): 2420-2430. DOI: 10.1007/s00415-017-8635-4.
|
| 6. |
Kezuka T, Ishikawa H. Diagnosis and treatment of anti-myelin oligodendrocyte glycoprotein antibody positive optic neuritis[J]. Jpn J Ophthalmol, 2018, 62(2): 101-108. DOI: 10.1007/s10384-018-0561-1.
|
| 7. |
Hennes EM, Baumann M, Schanda K, et al. Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome[J]. Neurology, 2017, 89(9): 900-908. DOI: 10.1212/WNL.0000000000004312.
|
| 8. |
Wynford-Thomas R, Jacob A, Tomassini V. Neurological update: MOG antibody disease[J]. J Neurol, 2019, 266(5): 1280-1286. DOI: 10.1007/s00415-018-9122-2.
|
| 9. |
徐敏, 郭虎, 何燕, 等. 兒童髓鞘少突膠質細胞糖蛋白抗體腦脊髓炎13例臨床與影像學特征[J]. 中華實用兒科臨床雜志, 2019, 34(13): 997-1001. DOI: 10.3760/cma.j.issn.2095-428X.2019.13.008.Xu M, Guo H, He Y, et al. Clinical and imaging features of 13 children with myelin oligodendrocyte glycoprotein antibody encephalomyelitis[J]. Journal of Applied Clinical Pediatrics, 2019, 34(13): 997-1001. DOI: 10.3760/cma.j.issn.2095-428X.2019.13.008.
|
| 10. |
張敏, 李文輝, 楊皓瑋, 等. 髓鞘少突膠質細胞糖蛋白抗體陽性的兒童中樞神經系統脫髓鞘病變首次發作的臨床和影像學特點[J]. 中華神經科雜志, 2018, 51(2): 97-104. DOI: 10.3760/cma.j.issn.1006-7876.2018.02.004.Zhang M, Li WH, Yang HW, et al. The clinical and radiological features of children with first attack of inflammatory demyelinating central nervous system disorders and seropositivity to myelin-oligodendrocyte glycoprotein[J]. Chin J Neurol, 2018, 51(2): 97-104. DOI: 10.3760/cma.j.issn.1006-7876.2018.02.004.
|
| 11. |
Hyun JW, Kwon YN, Lee HL, et al. Recurrence of clinical events at the same anatomical location in patients with MOG antibody-associated disease[J/OL].Mult Scler, 2020, 2020:E1[2020-03-31].http://journals.sagepub.com/doi/full/10.1177/1352458520913970?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed. DOI:10.1177/1352458520913970. [published online ahead of print].
|
